Symbol="BPMC"
AssetType="Common Stock"
Name="Blueprint Medicines Corp"
Description="Blueprint Medicines Corporation, a precision therapy company, develops drugs for people with cancer and blood disorders, and multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy in the United States and Europe. The company is headquartered in Cambridge, Massachusetts."
CIK="1597264"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="45 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3515569000"
EBITDA="-542129984"
PERatio="None"
PEGRatio="0"
BookValue="6.86"
DividendPerShare="0"
DividendYield="0"
EPS="-9.9"
RevenuePerShareTTM="3.419"
ProfitMargin="-2.84"
OperatingMarginTTM="-2.717"
ReturnOnAssetsTTM="-0.294"
ReturnOnEquityTTM="-0.897"
RevenueTTM="204592000"
GrossProfitTTM="177275000"
DilutedEPSTTM="-9.9"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.009"
AnalystTargetPrice="72.71"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="9.61"
PriceToBookRatio="4.367"
EVToRevenue="6.99"
EVToEBITDA="-2.728"
Beta="0.736"
num_52WeekHigh="79.4"
num_52WeekLow="37.82"
num_50DayMovingAverage="58.7"
num_200DayMovingAverage="49.73"
SharesOutstanding="60467000"
DividendDate="None"
ExDividendDate="None"
symbol="BPMC"
open="58.41"
high="58.74"
low="57.67"
price="58.14"
volume="875701.00"
latest_trading_day="2023-07-21"
previous_close="58.40"
change="-0.26"
change_percent="-0.4452%"
aroon_positive_momentum_days="65"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="65"
Volume_recent_avg="609210"
Change_recent_avg="0.22"
Delta_recent_avg="2.21"
Variance_recent_avg="1.1"
Change_ratio_recent_avg="0.38"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="1104"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0137.jpeg"
image_negative_thumbnail_id_2="1145"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0178.jpeg"
image_neutral_thumbnail_id_1="532"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_neutral_thumbnail_id_2="577"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0022.jpeg"
image_positive_thumbnail_id_1="697"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0011.jpeg"
image_positive_thumbnail_id_2="624"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0084.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
